Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Goodwill & Intangibles (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Goodwill & Intangibles for 10 consecutive years, with $202.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles rose 9.28% to $202.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $202.7 million, a 9.28% increase, with the full-year FY2025 number at $202.7 million, up 9.28% from a year prior.
  • Goodwill & Intangibles was $202.7 million for Q4 2025 at Orthopediatrics, up from $196.4 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $202.7 million in Q4 2025 to a low of $133.0 million in Q1 2021.
  • A 5-year average of $168.0 million and a median of $170.2 million in 2022 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: surged 279.95% in 2021, then decreased 1.86% in 2023.
  • Orthopediatrics' Goodwill & Intangibles stood at $142.1 million in 2021, then grew by 17.32% to $166.7 million in 2022, then increased by 2.69% to $171.2 million in 2023, then grew by 8.32% to $185.4 million in 2024, then grew by 9.28% to $202.7 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Goodwill & Intangibles are $202.7 million (Q4 2025), $196.4 million (Q3 2025), and $193.0 million (Q2 2025).